Back to Trades
Total Value
$9.0M
Net $9.0M sold
Filing Date
Aug 22, 2025
2 transactions
Sales
$9.0M
2 transactions
Trade Summary
On Aug 20, 2025 through Aug 21, 2025, Shanmugam Muthusamy, HEAD OF R&D, COO-NOVITIUM OPS, Director, sold $9.0M of ANI PHARMACEUTICALS INC (ANIP) across 2 transactions. The filing covers Common Stock and reflects net selling of $9.0M. Reported prices ranged from $90.27 to $90.44. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ANI PHARMACEUTICALS INC
- Ticker Symbol
- ANIP
- CIK
- 0001023024
Insider Information
- Role
- HEAD OF R&D, COO-NOVITIUM OPS, Director
- Location
- BAUDETTE, MN
Filing Details
- Filing Date
- Aug 22, 2025
- Transaction Date
- Aug 20, 2025
- Accession Number
- 0001870913-25-000008
- Form Type
- 4
- Net Trading Amount
- -$9.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 20, 2025 | Common Stock | 47,012 | $90.27 | Sale | $4.2M |
| Aug 21, 2025 | Common Stock | 52,988 | $90.44 | Sale | $4.8M |
Want live alerts when Shanmugam Muthusamy trades again?
Download Insider Trades to track ANIP, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The shares were sold in multiple trades at prices ranging from $89.21 to $90.83. The price reported above reflects the weighted average sales price.
- (F2)The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- (F3)The shares were sold in multiple trades at prices ranging from $89.90 to $91.44. The price reported above reflects the weighted average sales price.
- (F4)The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.